Lucas-Ruano Diego, Sanchez-Gomez Celia, Rihuete-Galve María Isabel, Garcia-Martin Alberto, Fonseca-Sanchez Emilio, Fernández-Rodríguez Eduardo José
Department of Nursing and Physiotherapy, Universidad de Salamanca, 37008 Salamanca, Spain.
Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
Healthcare (Basel). 2024 Aug 22;12(16):1675. doi: 10.3390/healthcare12161675.
Cancer is a leading cause of morbidity and mortality globally. Dyspnea, affecting up to 60% of cancer patients, exacerbates physical and psychological distress, reducing quality of life. This study aims to explore the relationship between dyspnea and factors such as age, sex, clinical diagnosis, and treatment lines in cancer patients, with the goal of improving understanding and management of this debilitating symptom to enhance patient care and quality of life.
This study employed an observational, cross-sectional, and descriptive approach to investigate patients with oncological disease at the University Hospital of Salamanca between March 2021 and April 2024. A convenience sample was selected, including patients over 18 years old with a pathological diagnosis of cancer, experiencing any degree of dyspnea, and who consented to participate by signing the informed consent. Exclusion criteria included lack of consent and clinical conditions that prevented an interview. The studied variables encompass sociodemographic (age, gender, diagnosis, tumor stage, number of treatment lines) and clinical aspects (daily activities, degree of dyspnea, functional capacity, physical performance), evaluated using the Barthel Index, the mMRC Dyspnea Scale, the ECOG Scale, and the Short Physical Performance Battery (SPPB). Data were collected through semistructured interviews and medical records, and analyzed using specialized software. This research has ethical approval CEiM Code 2023 12 1472, Reference 2024/01.
The mean age was 66.82 years. Lung cancer was predominant (60.2%), with most patients in stage 3 (65.7%) and receiving three treatment lines (68.7%). Higher age, advanced disease stage, and more treatment lines correlated with lower Barthel and SPPB scores, and higher ECOG and mMRC scores, indicating worse functionality, physical performance, and greater dyspnea. No significant correlations were found between gender or pathological diagnosis and the studied variables.
Advanced age, higher disease stage, and more treatment lines are associated with decreased functionality, poorer physical performance, and increased dyspnea in cancer patients. Gender and specific cancer diagnosis do not significantly affect these relationships. Addressing dyspnea is crucial to improving the quality of life and physical performance in this population. Future studies should explore additional factors like treatment types and nutritional status.
癌症是全球发病和死亡的主要原因。呼吸困难影响高达60%的癌症患者,加剧身体和心理痛苦,降低生活质量。本研究旨在探讨癌症患者呼吸困难与年龄、性别、临床诊断和治疗线数等因素之间的关系,以增进对这种使人衰弱症状的理解和管理,从而改善患者护理和生活质量。
本研究采用观察性、横断面和描述性方法,对2021年3月至2024年4月期间萨拉曼卡大学医院的肿瘤疾病患者进行调查。选取了一个便利样本,包括年龄超过18岁、经病理诊断为癌症、有任何程度呼吸困难且通过签署知情同意书同意参与的患者。排除标准包括不同意参与和妨碍访谈的临床状况。研究变量包括社会人口统计学(年龄、性别、诊断、肿瘤分期、治疗线数)和临床方面(日常活动、呼吸困难程度、功能能力、身体表现),使用Barthel指数、mMRC呼吸困难量表、ECOG量表和简短身体表现量表(SPPB)进行评估。通过半结构化访谈和病历收集数据,并使用专门软件进行分析。本研究已获得伦理批准,CEiM代码2023 12 1472,参考文献2024/01。
平均年龄为66.82岁。肺癌占主导(60.2%),大多数患者处于3期(65.7%)且接受三线治疗(68.7%)。年龄较大、疾病分期较晚和治疗线数较多与较低的Barthel和SPPB评分以及较高的ECOG和mMRC评分相关,表明功能、身体表现较差且呼吸困难更严重。在性别或病理诊断与研究变量之间未发现显著相关性。
高龄、疾病分期较高和治疗线数较多与癌症患者功能下降、身体表现较差和呼吸困难增加有关。性别和特定癌症诊断对这些关系没有显著影响。解决呼吸困难对于改善该人群的生活质量和身体表现至关重要。未来的研究应探索其他因素,如治疗类型和营养状况。